Midazolam
Midazolam is a pharmaceutical drug with 725 clinical trials. Currently 54 active trials ongoing. Historical success rate of 91.6%.
Success Metrics
Based on 510 completed trials
Phase Distribution
Phase Distribution
343
Early Stage
53
Mid Stage
208
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.9%
510 of 580 finished
12.1%
70 ended early
54
trials recruiting
725
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy
Clinical Trials (725)
Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy
A Phase 1, First-in-human Study of VX-433
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Comparing the Outcome of Buccal Midazolam and Intramuscular Midazolam in Children Presenting With Seizures.
Effect of Obesity on Proton Pump Inhibitors
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
Ketamine for Multiple Sclerosis Fatigue
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Predictors of Intravenous Ketamine Response in TRD
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 725